MedTrace Logo

Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience

NCT02557750 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2023-07-24

No results posted yet for this study

Summary

The aim of this study is to retrospectively investigate the effect of combined modality treatment of pediatric hepatoblastoma and the factors affecting the prognosis in accordance with the experience at the pediatric oncology department at South Egypt Cancer Institute.

Conditions

  • Hepatoblastoma

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2023-09-30
Completion
2023-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02557750 on ClinicalTrials.gov